$18 million awarded to TGen and University of Pennsylvania for pancreatic cancer research
PHOENIX, Ariz. May 27, 2009 The Translational Genomics Research Institute (TGen) and the University of Pennsylvania (Penn) will receive $18 million to research pancreatic cancer, Stand Up to Cancer (SU2C) announced today.
Dr. Daniel Von Hoff, TGen's Physician-In-Chief, and Dr. Craig B. Thomps...
Helios Education Foundation Invests $6.5 Million in New Partnership with TGen
Partnership Extends Funding for Bioscience Summer Internship Program Over the Next 25 Years
PHOENIX, Jan. 29 /PRNewswire/ -- Helios Education Foundation today
awarded $6.5 million to the Translational Genomics Research Institute
(TGen) as part of a new partnership that...
Gene linked to increasingly common type of blood cancer
...on-Hodgkin lymphoma, scientists at UC Berkeley and tgen
identified a SNP a single nucleotide polymorphism... This same pooling technique has been pioneered by tgen
to screen for genes in other studies. Additional collaborations between UC Berkeley and tgen
"This study paves the way for more...
TGen and USC researchers find genetic markers to help fight diabetes
...fewer side-effects, for patients with diabetes.
Senior Investigator Dr. Johanna DiStefano presente...ctive means to prevent the disease.
and Keck investigators found that genetic variatio...tify other variants that predict response to TZDs, tgen
researchers performed a genome-wide analysis of 11...
Cancer Researcher Dan Von Hoff, M.D. Advocates for "Context of Vulnerability," A Powerful New Paradigm for Targeted Drug Development
... Renowned cancer researcher Dr. Daniel Von Hoff and his team at tgen
are fervent believers in a new approach to developing novel therapies for patients with pancreatic cancer. They are guided by a rationale dubbed the &...
Van Andel Research Institute of Michigan and Translational Genomics Research Institute of Arizona Undertake Unprecedented Alliance to Promote Science and Health
... Rapids, Mich.-based VARI and Phoenix,
will enable both institutes to speed up their mutu...Betty Van Andel.
"We are excited to welcome tgen
as they combine forces with us in our
mission to c...n Andel. "This alliance demonstrates that VARI and tgen
are at the forefront
of redefining a borderless, c...
Ivy Foundation Funds New Brain Cancer Research Consortium : $3M Stage I Project Aims to Improve Personalized Medicine for Patients
...n). Under the leadership of Michael Berens, Ph.D., tgen
will coordinate and manage the two-stage project s...tute
"We are proud to partner with tgen
and these fine institutions on a project that exem...r each patient diagnosed with a brain tumor. About tgen
Translational Genomics Research Institute ...
Caris Diagnostics Providing KRAS Mutational Analysis for Colon Cancer Patients
...for the assessment of response to Erbitux and Vectibix,"
said Dr. Daniel Von Hoff, Executive Director of Caris MPI's Pharmaceutical
Services division, tgen
Physician in Chief, and Chief Scientific Officer of
US Oncology. "I think the oncology community is looking forward to having
this type of information...
Researchers close in on new melanoma gene
...their colleagues identify a region on chromosome 20 (20q11.22) that influences a persons risk of developing melanoma.
According to Dr Kevin Brown, tgen
Investigator and the papers co-first author, compared to other genetic research focusing on familial (or inherited) cases of melanoma, this finding ho...
Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis
... SEATTLE, Dec. 3 /PRNewswire-FirstCall/ -- Targeted Genetics Corporation
) today reported on the National Institutes of Health (NIH)
Recombinant DNA Advisory Committee's (RAC) assessment of the previously
reported fatal ser...
TGen in Medical Technology
febit and TGen Collaborate to Study New DNA Capture Method
febit's HybSelect(TM) Technology Evaluated to Enable Targeting and Increase Speed for Next-Generation-Sequencing
LEXINGTON, Mass. and HEIDELBERG, Germany, Aug. 14 /PRNewswire/ -- febit
and the Translational Genomics Research Institute (TGen) today announced
the formation of a co...
Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease
...formation, visit www.shri.org .
The Translational Genomics Research Institute ...g research with life changing results. Research at tgen
is focused on helping patients with diseases such as cancer, neurological disorders and diabetes. tgen
is on the cutting edge of translational research w...
VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology
... of VTX-2337, a selective TLR8 agonist for the treatment of cancer. The multi-center clinical trial is being conducted at the Mayo Clinic Arizona and tgen
Drug Development Services (TD2) both in Scottsdale, Arizona.
"We are delighted to advance the first molecule from our Toll-Like Receptor 8 p...
Unibioscreen and Drais Pharmaceuticals Partner to Develop and Commercialize UNBS 5162 for Treatment of Cancer
...increases the therapeutic benefits of
The Phase I trial is currently being conducted under the supervision of
Daniel Von Hoff, M.D. at tgen
Clinical Research Services at The Virginia G.
Piper Cancer Center at Scottsdale Healthcare, Mayo Clinic Scottsdale and
the University of Arizona Cance...
Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology
... SEATTLE and PARIS, June 12 /PRNewswire-FirstCall/ -- Targeted Genetics
Corporation (Nasdaq: tgen
) announced today that positive results of a Phase
1/2 clinical study demonstrate that tgAAC94, its investigational agent
designed to inhibit activity...
Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
... SEATTLE, Sept. 17 /PRNewswire-FirstCall/ -- Targeted Genetics
Corporation (Nasdaq: tgen
) today reported on the public hearing conducted
by the National Institutes of Health (NIH) Recombinant DNA Advisory
Committee (RAC), which reviewed t...
Prolexys Pharmaceuticals Initiates Phase 1 Study
...igned to evaluate the safety,
pharmacokinetic and pharmacodynamic properties of PRLX 93936 in patients
with advanced solid tumors. Study sites include tgen
Clinical Research at
Scottsdale Healthcare in Scottsdale, Arizona, and Tower Cancer Research
Foundation in Beverly Hills, California. The first Phase ...
ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
... ImmuneRegen and tgen
Continue Testing Possible Treatment for Acute
Ra...Inc. "We are very happy that
our relationship with tgen
continues to develop a promising collection of
dat...e the mechanism of
leukocyte replenishment. About tgen
The Translational Genomics Research Institute (TG...
IR BioSciences Announces Data Demonstrating Radilex Stimulation of
Stem Cells Results in Hematopoietic Recovery Following Lethal
...r this finding regarding Radilex.
Continuing radiation studies will be performed at both the
Translational Genomics Research Institute (TGen) and tgen
Development Services (TD2, its drug development arm) and at the
Pacific Northwest National Laboratory to further explore the impact
of radiation ...
Idera Pharmaceuticals Announces Presentations of Preclinical Data
on New Potential Oncology Applications of its TLR9 Agonists at AACR
...ate (Nexavar(R)) demonstrates
enhanced antitumor activity in a human non-small cell lung cancer
xenograft model," was presented by Bernardo Chavira of tgen
Development Services in the session Cancer Therapeutics 2. The
combination of IMO-2055 and sorafenib in the study lead to
increased antitumor eff...
TGen in Medical Definition
...ne Coalition , a group of companies and research institutions devoted to the promotion of personalized medicine
, Translational Genomics Research Institute at Arizona State University.
Sinai Hospital, New York City
Personalized Medicine . A peer-reviewed ...
TGen in Biological News
Breast health center gives TGen new research opportunities
PHOENIX, Ariz. May 4, 2009 Today's opening of a new breast health center next to John C. Lincoln Deer Valley Hospital will provide significant research opportunities for the Translational Genomics Research Institute (TGen).
The 9,000-square-foot Breast Health and Research Center will include ...
Safeway gives $685,000 to TGen for breast cancer research
PHOENIX, Ariz. March 4, 2009 Despite a down economy, Safeway Inc. presented a $685,236 check this week for breast cancer research at the Translational Genomics Research Institute (TGen).
Dan Valenzuela, President of Safeway's Phoenix Division, which includes 116 stores throughout Arizona, tha...
Van Andel Research Institute and TGen undertake alliance to promote science and health
PHOENIX, Ariz. Feb. 11, 2009 The Van Andel Research Institute (VARI) and the Translational Genomics Research Institute (TGen) will forge a strategic alliance that will enable both to maximize their worldwide contributions to science and health.
The non-profit researcher institutes jointly ann...
House Ear Institute, TGen and Belgian researchers identify gene in age-related hearing loss
LOS ANGELES, Calif. Dec. 2, 2008 Presbycusis, or age-related hearing loss, accounts for 30 percent of all hearing loss. So, why do some people lose their hearing as they get older but other people can still hear a pin drop?
The answer may be in a study released online in the journal Human...
Supercomputer provides massive computational boost to biomedical research at TGen
PHOENIX, Ariz. Oct. 29, 2008 -- In less time than the blink of an eye, the Translational Genomics Research Institute's new supercomputer at Arizona State University can do operations equal to every dollar in the recent Wall Street bailout.
That would be 700 billion computations in less than 1/...
Advances in lung cancer research announced at conference
...Gen's Cancer and Cell Biology Division and Director of Thoracic Oncology at tgen
Clinical Research Services at Scottsdale Healthcare, made both announcement...ording to the team, which was funded by the Ibis Foundation of Arizona, the tgen
Foundation and the Scottsdale Healthcare Foundation.
"With additional v...
TGen researchers discover possible way to block the spread of deadly brain tumors
Dr. Berens, the paper's senior author, said the advances made by tgen
not only confirm NHERF-1 as a gene associated with brain tumors, but also p...contributing to the malignant behavior of the disease," Dr. Berens said.
scientists are scheduled to present their findings at the 100th annual meet...
TGen helps promote cancer awareness for vast Navajo Nation
...titute (TGen) extend to the far corners of Arizona.
For the second year, tgen
will help organize a cancer awareness conference for northeastern Arizona's...'
Kavanagh praised as top-notch the presentation by Dr. Bodour Salhia, a tgen
post-doctorate fellow who is investigating breast cancer and multiple myelo...
TGen's Dr. Von Hoff wins award for cancer research
...n cancer research.
Dr. Von Hoff, who also is Chief Scientific Officer of tgen
Clinical Research Services at Scottsdale Healthcare, will be recognized in ... have led to 12 patents.
Through the three-year-old partnership between tgen
and Scottsdale Healthcare, Dr. Von Hoff leads a nearly 40-member staff in t...
TGen Clinical Research Services at Scottsdale Healthcare and Mayo Clinic study new cancer drug
... SCOTTSDALE, Ariz. Jan. 29, 2008 tgen
Clinical Research Services (TCRS) at Scottsdale Healthcare and Mayo Clinic ...solid tumors.
Clinical trials of the drug TH-302 are being conducted at tgen
Clinical Research Services at Scottsdale Healthcare, a partnership of the P...
TGen in Biological Technology
Mersana Reports Preliminary Phase 1 Results of XMT-1001 in Patients with Advanced Solid Tumors
...S. Anthony, D. Shkolny, A. V. Yurkovetskiy, C. Bethune, R. J. Fram; University of Maryland, Baltimore , MD; New York Oncology Hematology, Albany, NY; tgen
Clinical Research Services, Scottsdale, AZ; Mersana Therapeutics, Inc., Cambridge, MA; Covance Bioanalytical, Madison, WI
Paul Keim Appointed to febit's Scientific Advisory Board
...cruitment of Paul Keim, Ph.D., for its Scientific Advisory Board. Dr. Keim is Senior Investigator and Director of the Pathogen Genomics Division at tgen
(The Translational Genomics Research Institute) in Phoenix, Ariz., and Regents Prof. of Biology at the Northern Arizona University . As an expert i...
Automated Sequence Capture for Next-Generation Sequencing Paves the Way for Personalized Medicine
... confirmed by early access customers. Dr. Matthew Huentelman, an investigator and lead collaborator at the Translational Genomics Research Institute ( tgen
) in Phoenix, AZ, was one of the first researchers to use HybSelect. His laboratory uses state-of-the-art techniques to pin-point differences in genes...
Clarification on Press Release Issued Earlier Today: Targeted Genetics Confirms Positive, Interim Phase 1/2 Study Findings
...ther Clinical Development of tgAAC94
BOSTON and SEATTLE, May 30 /PRNewswire-FirstCall/ -- Targeted Genetics
Corporation (Nasdaq: tgen
) issued a news release earlier today, entitled
"Targeted Genetics Reports Additional Data From Inflammatory Arthritis
Clinical Trial," announcing add...
SGI Breakthrough Technology Empowers Genome Center Research Around the World
... Translational Genomics Research Institute
deploys technology from SGI to more quickly and ef...rant, the SGI(R) Altix(R)
4700 system is assisting tgen
researchers in understanding the genomic
Since implementing the SGI system, tgen
has observed significant
performance gains in anal...
Seth Dobin heading up Marshfield's Mammalian Genotyping Service
...rshfield Clinic, Dobrin brings extensive research experience of his own to the Center for Human Genetics. During his time as a post-doctoral fellow at tgen
in Phoenix, Dobrin identified the first genetic marker for sudden infant death syndrome (SIDS). He also was involved in identifying the first gene ass...
GE Healthcare partners with genomics institute
... pharmaceutical genomics and cancer drug development for TGen, said in a statement.
Mousses also said the imaging systems provided by GE will allow tgen
to observe cellular morphology more clearly and perform cytometry at an unprecedented rate. Most importantly, the institute's researchers will more ac...